Addressing Sickle Cell Disease : A Strategic Plan and Blueprint for Action

個数:

Addressing Sickle Cell Disease : A Strategic Plan and Blueprint for Action

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 522 p.
  • 言語 ENG
  • 商品コード 9780309669603
  • DDC分類 616.1527

Full Description

Sickle cell disease (SCD) is a genetic condition that affects approximately 100,000 people in the United States and millions more globally. Individuals with SCD endure the psychological and physiological toll of repetitive pain as well as side effects from the pain treatments they undergo. Some adults with SCD report reluctance to use health care services, unless as a last resort, due to the racism and discrimination they face in the health care system. Additionally, many aspects of SCD are inadequately studied, understood, and addressed.

Addressing Sickle Cell Disease examines the epidemiology, health outcomes, genetic implications, and societal factors associated with SCD and sickle cell trait (SCT). This report explores the current guidelines and best practices for the care of patients with SCD and recommends priorities for programs, policies, and research. It also discusses limitations and opportunities for developing national SCD patient registries and surveillance systems, barriers in the healthcare sector associated with SCD and SCT, and the role of patient advocacy and community engagement groups.

Table of Contents

Front Matter
Summary
1 Introduction
2 Societal and Structural Contributors to Disease Impact
3 Screening, Registries, and Surveillance
4 Complications of Sickle Cell Disease and Current Management Approaches
5 Health Care Organization and Use
6 Delivering High-Quality Sickle Cell Disease Care with a Prepared Workforce
7 Developing and Delivering the Next Generation of Therapies
8 Community Engagement and Patient Advocacy
9 Strategic Plan and Blueprint for Sickle Cell Disease Action
Appendix A: Public Meeting Agendas and Submissions to the Committee
Appendix B: Literature Search Terms and Strategy
Appendix C: Committee and Staff Biographies
Appendix D: Newborn Screening Results Reporting Protocols for Sickle Cell Disease and Sickle Cell Trait
Appendix E: Sickle Cell Data Collection Program
Appendix F: Georgia Comprehensive Sickle Cell Center: A Case Study
Appendix G: Emory Adult Cystic Fibrosis Program
Appendix H: Health Resources and Services Administration Sickle Cell Disease Programs
Appendix I: Select Treatments Currently Under Development for Sickle Cell Disease
Appendix J: Other Training Models for Hematologists
Appendix K: Sickle Cell Community-Based Organizations and Patient Groups in the United States
Appendix L: Summary Table of Strategic Plan and Blueprint for Sickle Cell Disease Action
Appendix M: Summary Table of Sickle Cell Trait Discussion in Report
Appendix N: Glossary

最近チェックした商品